4
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Naltrexone maintenance for heroin dependence: uptake, attrition and retention

, , &
Pages 299-309 | Received 24 Jul 2003, Accepted 01 Apr 2004, Published online: 12 Jul 2009
 

Abstract

With naltrexone registered only recently in Australia in 1999, it is important to examine the rate of uptake of naltrexone treatment, early attrition and retention rates during treatment, in order to inform the way naltrexone is used in Australian practice. Of 317 people screened for the study, 97 participants were recruited post-withdrawal from opiates and were inducted to naltrexone after a period of at least 5 days of abstinence. While in treatment, participants received a 50-mg dose of naltrexone daily, with daily dispensing for the first 7 days, and weekly dispensing for the following 11 weeks. For the naltrexone-treated sample as a whole, the rate of uptake of naltrexone treatment was 30%, with 30% retained in treatment for the entire 12-week program. Attrition from treatment was found to be steady throughout the 12 weeks. The authors conclude that further research is required to improve withdrawal and naltrexone induction techniques and to improve medication compliance and treatment retention. [Tucker TK, Ritter AJ, Maher C, Jackson H. Naltrexone maintenance for heroin dependence: uptake, attrition and retention. Drug Alcohol Rev 2004;23:299–309]

Dr Thamizan K. Tucker, Doctor of Psychology, c/o Turning Point Alcohol and Drug Centre, Inc., 54 – 62 Gertrude Street, Fitzroy, Victoria, 3065, Australia, Dr Alison J. Ritter, Head of Research, Turning Point Alcohol and Drug Centre, Inc., 54 – 62 Gertrude Street, Fitzroy, Victoria, 3065, Australia, Claire Maher, Research Assistant, Turning Point Alcohol and Drug Centre, Inc., 54 – 62 Gertrude Street, Fitzroy, Victoria, 3065, Australia, Professor Henry Jackson, Department of Psychology, The University of Melbourne, Parkville, Victoria, 3052, Australia.

Dr Thamizan K. Tucker, Doctor of Psychology, c/o Turning Point Alcohol and Drug Centre, Inc., 54 – 62 Gertrude Street, Fitzroy, Victoria, 3065, Australia, Dr Alison J. Ritter, Head of Research, Turning Point Alcohol and Drug Centre, Inc., 54 – 62 Gertrude Street, Fitzroy, Victoria, 3065, Australia, Claire Maher, Research Assistant, Turning Point Alcohol and Drug Centre, Inc., 54 – 62 Gertrude Street, Fitzroy, Victoria, 3065, Australia, Professor Henry Jackson, Department of Psychology, The University of Melbourne, Parkville, Victoria, 3052, Australia.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.